[go: up one dir, main page]

DE69432486D1 - Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen - Google Patents

Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen

Info

Publication number
DE69432486D1
DE69432486D1 DE69432486T DE69432486T DE69432486D1 DE 69432486 D1 DE69432486 D1 DE 69432486D1 DE 69432486 T DE69432486 T DE 69432486T DE 69432486 T DE69432486 T DE 69432486T DE 69432486 D1 DE69432486 D1 DE 69432486D1
Authority
DE
Germany
Prior art keywords
virus
cav
proteins
induction
infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69432486T
Other languages
English (en)
Other versions
DE69432486T2 (de
Inventor
Mathieu Hubertus Maria Noteborn
Guus Koch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leadd BV
Original Assignee
Leadd BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leadd BV filed Critical Leadd BV
Publication of DE69432486D1 publication Critical patent/DE69432486D1/de
Application granted granted Critical
Publication of DE69432486T2 publication Critical patent/DE69432486T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69432486T 1993-07-20 1994-07-19 Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen Expired - Fee Related DE69432486T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL9301272A NL9301272A (nl) 1993-07-20 1993-07-20 Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
NL9301272 1993-07-20
PCT/NL1994/000168 WO1995003414A2 (en) 1993-07-20 1994-07-19 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor

Publications (2)

Publication Number Publication Date
DE69432486D1 true DE69432486D1 (de) 2003-05-15
DE69432486T2 DE69432486T2 (de) 2004-03-04

Family

ID=19862681

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69435117T Expired - Fee Related DE69435117D1 (de) 1993-07-20 1994-07-19 Hühner-Anaemie-Virus Mutante, Impfstoffe, und Verwendungen basiert auf Virusprotein VP3, oder dafür kodierende Virus-Sequenzen
DE69432486T Expired - Fee Related DE69432486T2 (de) 1993-07-20 1994-07-19 Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69435117T Expired - Fee Related DE69435117D1 (de) 1993-07-20 1994-07-19 Hühner-Anaemie-Virus Mutante, Impfstoffe, und Verwendungen basiert auf Virusprotein VP3, oder dafür kodierende Virus-Sequenzen

Country Status (13)

Country Link
US (1) US5952002A (de)
EP (2) EP1253201B1 (de)
JP (1) JP3829290B2 (de)
AT (2) ATE401406T1 (de)
AU (1) AU703187B2 (de)
CA (1) CA2167578C (de)
DE (2) DE69435117D1 (de)
DK (2) DK0784685T3 (de)
ES (2) ES2196032T3 (de)
NL (1) NL9301272A (de)
PT (2) PT1253201E (de)
WO (1) WO1995003414A2 (de)
ZA (1) ZA945275B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922600A (en) * 1990-09-12 1999-07-13 Leadd Bv Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
EP0872552A1 (de) * 1997-04-15 1998-10-21 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 induzierendes Protein und/oder Apoptin exprimiert
EP0878546A1 (de) * 1997-04-15 1998-11-18 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
CA2221495C (en) * 1995-06-07 2010-06-01 Aesculaap B.V. Methods and uses for apoptin
JPH11510367A (ja) * 1995-06-07 1999-09-14 アエスキュラープ ビー．ヴィ． ニワトリ貧血ウイルスの中和性立体配座エピトープ
EP0927757A1 (de) 1997-12-03 1999-07-07 Leadd B.V. Verfahren und Mitteln um Apoptose zu induzieren durch Interferenz mit Bip-ähnliche Proteine
US7361730B1 (en) * 1999-03-15 2008-04-22 University Of Maryland Surface localized colligin/Hsp47 in carcinoma cells
EP1199363A1 (de) * 2000-10-20 2002-04-24 Leadd B.V. Phosphorylationsmodifikationen von Apoptin
AUPR567401A0 (en) 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines
PT2371383E (pt) 2005-12-29 2015-11-24 Boehringer Ingelheim Vetmed Utilização de uma composição imunogénica de pcv2 para atenuar os sintomas clínicos em porcos
MX365868B (es) 2005-12-29 2019-06-18 Boehringer Ingelheim Vetmedica Inc Composiciones inmunogenicas de pcv2 multivalentes y metodos de producir composiciones de este tipo.
CN102311928B (zh) * 2011-08-25 2013-04-24 中国农业科学院哈尔滨兽医研究所 鸡贫血病毒vp1、vp2蛋白共表达的重组酵母工程菌、其构建方法及应用
WO2017066772A1 (en) 2015-10-16 2017-04-20 Kansas State University Research Foundation Porcine circovirus type 3 immunogenic compositions and methods of making and using the same
WO2017187131A1 (en) * 2016-04-26 2017-11-02 London School Of Hygiene & Tropical Medicine Reoviridae vaccine
CN113980146B (zh) * 2021-11-11 2022-09-27 扬州优邦生物药品有限公司 三聚体化鸭黄病毒E蛋白domainIII、其制备方法和运用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
ZA927014B (en) * 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.

Also Published As

Publication number Publication date
EP1253201B1 (de) 2008-07-16
DK1253201T3 (da) 2008-11-17
AU703187B2 (en) 1999-03-18
NL9301272A (nl) 1995-02-16
DK0784685T3 (da) 2003-08-04
EP0784685A2 (de) 1997-07-23
ES2311005T3 (es) 2009-02-01
ATE236980T1 (de) 2003-04-15
ES2196032T3 (es) 2003-12-16
DE69435117D1 (de) 2008-08-28
CA2167578A1 (en) 1995-02-02
WO1995003414A3 (en) 1995-03-02
CA2167578C (en) 2007-03-13
ATE401406T1 (de) 2008-08-15
EP1253201A2 (de) 2002-10-30
ZA945275B (en) 1995-02-24
PT1253201E (pt) 2008-10-27
AU7547394A (en) 1995-02-20
JP3829290B2 (ja) 2006-10-04
US5952002A (en) 1999-09-14
PT784685E (pt) 2003-08-29
EP0784685B1 (de) 2003-04-09
EP1253201A3 (de) 2003-01-08
WO1995003414A2 (en) 1995-02-02
DE69432486T2 (de) 2004-03-04
JPH09504941A (ja) 1997-05-20

Similar Documents

Publication Publication Date Title
DE69432486D1 (de) Huehner-anaemie-virus mutante, impfstoffe, und verwendung basiert auf virusproteinen vp1, vp2 und vp3, oder dafuer kodierende virus-sequenzen
DE69519521D1 (de) Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
CY1115749T1 (el) Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια
DE69536039D1 (de) Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert
ES8500322A1 (es) Un metodo de modificar un virus para conferirle una nueva funcion biologica.
ATE386106T1 (de) Rekombinante poxvirus-cytomegalovirus zusammensetzungen und ihre verwendung
DK84194A (da) Rekombinant hepatitis B-virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenetiske polypeptider, DNA-sekvenser kodende herfor, fremgangsmåder til påvisning af hepatitis B-virus antistoffer i blodserum, fremgangsmåder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider, midler til påvisn
CN86102858A (zh) 制备猪支原体的重组表面抗原及其疫苗的方法
FI861485A (fi) Producering av immunologiskt reaktiva virala proteiner.
DE3853139D1 (de) Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
DE3689622D1 (de) Impfstoffe gegen menschliche respiratorische viren.
DE3752131D1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
DE69019359D1 (de) Menschliche parvovirus-b19-proteine und virusähnliche partikeln, deren herstellung sowie deren verwendung in diagnostischen tests und in impfstoffen.
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
CN105797152A (zh) 一种疫苗组合物及其制备方法和应用
DE3776034D1 (de) Vakzine.
BR9508645B1 (pt) seqÜÊncia de nucleotÍdeos isolada compreendendo o gene s fipv tendo uma seqÜencia de nucleotÍdeos da cepa 79-1146 fipv, bem como polipeptÍdeo, vacina e composiÇço compreendendo a mesma.
DE69019092D1 (de) Von Babesia abgeleitete Antigene und Polypeptide (12D3-Antigen).

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee